Teva Pharmaceutical Industries (TEVA) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.67 Bn | 42.71 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.16 Bn | 39.51 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.26 Bn | 19.59 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.80 Bn | 17.91 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - | 3.94% |
| 10 | Alkermes | 8.28 Bn | 7.62 Bn | 397.90 Mn | -8.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.34% |
| Mar 31, 2026 | -13.67% |
| Dec 31, 2025 | -10.94% |
| Sep 30, 2025 | -15.02% |
| Jun 30, 2025 | -13.69% |
| Mar 31, 2025 | -17.57% |
| Dec 31, 2024 | -20.33% |
| Sep 30, 2024 | 0.89% |
| Jun 30, 2024 | -2.43% |
| Mar 31, 2024 | -2.31% |
| Dec 31, 2023 | 0.19% |
| Sep 30, 2023 | 0.97% |
| Jun 30, 2023 | -0.49% |
| Mar 31, 2023 | -3.05% |
| Dec 31, 2022 | -4.06% |
| Sep 30, 2022 | -7.81% |
| Jun 30, 2022 | -6.32% |
| Mar 31, 2022 | -2.95% |
| Dec 31, 2021 | -4.99% |
| Sep 30, 2021 | -1.82% |